Publications by authors named "Takeshi Ujike"

Claim this Profile
[
[PROGNOSTIC FACTORS FOR METASTATIC UROTHELIAL CARCINOMA IN THE IMMUNOTHERAPY ERA].
Yuichi Tsujimoto, Makishi Nakamura, Yutaka Kurahashi, Shunsuke Mori, Ryoya Mizuno, Takeshi Ujike

Nihon Hinyokika Gakkai Zasshi· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative CRP is a predictive factor for prolonged hospital stay after radical cystectomy for bladder cancer.
Takuji Hayashi, Atsunari Kawashima, Takeshi Ujike, Tetsuya Takao, Mototaka Sato

BMC Urol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GDF15 propeptide promotes bone metastasis of castration-resistant prostate cancer by augmenting the bone microenvironment.
Gaku Yamamichi, Taigo Kato, Noriaki Arakawa, Yoko Ino, Takeshi Ujike

Biomark Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of enzalutamide long-term safety and efficacy for castration-resistant prostate cancer patients after combined anti-androgen blockade followed by alternative anti-androgen therapy: a multicenter prospective DELC study.
Akira Nagahara, Motohide Uemura, Mototaka Sato, Wataru Nakata, Masao Tsujihata, Takeshi Ujike

Jpn J Clin Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic and prognostic significance of tartrate-resistant acid phosphatase type 5b in newly diagnosed prostate cancer with bone metastasis: A real-world multi-institutional study.
Gaku Yamamichi, Taigo Kato, Satoru Yumiba, Eisuke Tomiyama, Yoko Koh, Takeshi Ujike

Int J Urol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early dynamics of circulating tumor DNA predict clinical response to immune checkpoint inhibitors in metastatic renal cell carcinoma.
Yoko Koh, Kosuke Nakano, Kotoe Katayama, Gaku Yamamichi, Satoru Yumiba, Takeshi Ujike

Int J Urol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative circulating tumor DNA enables the identification of patients with poor prognosis in upper tract urothelial carcinoma.
Kosuke Nakano, Yoko Koh, Gaku Yamamichi, Satoru Yumiba, Eisuke Tomiyama, Takeshi Ujike

Cancer Sci· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel diagnostic model for bone metastases in renal cell carcinoma patients based on bone scintigraphy analyzed by computer-aided diagnosis software and bone turnover markers.
Takeshi Ujike, Motohide Uemura, Taigo Kato, Koji Hatano, Atsunari Kawashima

Int J Clin Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful separation of male pygopagus with anal canal and urethral reconstruction: a case report.
Chiyoshi Toyama, Motonari Nomura, Yuko Tazuke, Chisato Yokota, Naoki Kagawa, Takeshi Ujike

Surg Case Rep· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world Outcomes of Tyrosine Kinase Inhibitors Immediately After Immune Checkpoint Inhibitors in Renal Cell Carcinoma.
Taigo Kato, Akira Nagahara, Norihiko Kawamura, Wataru Nakata, Tetsuji Soda, Takeshi Ujike

Anticancer Res· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Laparoscopic resection of aortocaval paraganglioma diagnosed by serial increase in urinary metanephrines after bilateral adrenalectomy in a patient with multiple endocrine neoplasia type 2A.
Yushi Miyata, Koji Hatano, Yosuke Okuno, Takeshi Ujike, Shinichiro Fukuhara

IJU Case Rep· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gut Microbiota-Derived Short-Chain Fatty Acids Promote Prostate Cancer Growth via IGF1 Signaling.
Makoto Matsushita, Kazutoshi Fujita, Takuji Hayashi, Hisako Kayama, Daisuke Motooka, Takeshi Ujike

Cancer Res· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[A Case of Para-Aortic Lymph Node Metastasis 10 Years after Transurethral Resection for Non-Muscle Invasive Bladder Cancer].
Yuki Horibe, Takeshi Ujike, Shinichiro Fukuhara, Kazutoshi Fujita, Hiroshi Kiuchi

Hinyokika Kiyo· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic and Clinical Outcomes of Robot-assisted Partial Nephrectomy Cryoablation for T1 Renal Cell Carcinoma.
Toshihiro Uemura, Taigo Kato, Akira Nagahara, Atsunari Kawashima, Koji Hatano, Takeshi Ujike

In Vivo· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic impact of immune-related adverse events in metastatic renal cell carcinoma patients treated with nivolumab: a real-world multi-institutional retrospective study.
Taigo Kato, Akira Nagahara, Norihiko Kawamura, Wataru Nakata, Tetsuji Soda, Takeshi Ujike

Int J Clin Oncol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic analysis of urinary and tissue-exudative extracellular vesicles to discover novel bladder cancer biomarkers.
Eisuke Tomiyama, Kyosuke Matsuzaki, Kazutoshi Fujita, Takashi Shiromizu, Ryohei Narumi, Takeshi Ujike

Cancer Sci· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic and Pathological Characterization of Multiple Renal Cell Carcinoma Regions in Patient With Tuberous Sclerosis Complex: A Case Report.
Tetsuya Yamamoto, Taigo Kato, Koji Hatano, Atsunari Kawashima, Takeshi Ujike

Front Oncol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High detection rate in [F]PSMA-1007 PET: interim results focusing on biochemical recurrence in prostate cancer patients.
Tadashi Watabe, Motohide Uemura, Fumihiko Soeda, Sadahiro Naka, Takeshi Ujike

Ann Nucl Med· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MiR-30b-3p and miR-126-3p of urinary extracellular vesicles could be new biomarkers for prostate cancer.
Kyosuke Matsuzaki, Kazutoshi Fujita, Eisuke Tomiyama, Koji Hatano, Yujiro Hayashi, Takeshi Ujike

Transl Androl Urol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fragmentation of cell-free DNA is induced by upper-tract urothelial carcinoma-associated systemic inflammation.
Kosuke Nakano, Yoshiyuki Yamamoto, Gaku Yamamichi, Satoru Yumiba, Eisuke Tomiyama, Takeshi Ujike

Cancer Sci· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral T cell receptor repertoire features predict durable responses to anti-PD-1 inhibitor monotherapy in advanced renal cell carcinoma.
Taigo Kato, Kazuma Kiyotani, Eisuke Tomiyama, Yoko Koh, Makoto Matsushita, Takeshi Ujike

Oncoimmunology· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Failure to achieve castrate level of serum testosterone during luteinizing hormone-releasing hormone agonist therapy in a patient with prostate cancer.
Yoko Koh, Atsunari Kawashima, Takeshi Ujike, Akira Nagahara, Kazutoshi Fujita

Anticancer Drugs· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of prophylactic selective arterial embolization for renal angiomyolipomas: identifying predictors of 50% volume reduction.
Hidenari Hongyo, Hiroki Higashihara, Keigo Osuga, Eiji Kashiwagi, Shinya Kosai, Takeshi Ujike

CVIR Endovasc· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Potential Mechanism of Anticancer Immune Response Coincident With Immune-related Adverse Events in Patients With Renal Cell Carcinoma.
Taigo Kato, Eisuke Tomiyama, Yoko Koh, Makoto Matsushita, Yujiro Hayashi, Takeshi Ujike

Anticancer Res· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of Nectin-4 and PD-L1 in Upper Tract Urothelial Carcinoma.
Eisuke Tomiyama, Kazutoshi Fujita, Maria Del Carmen Rodriguez Pena, Diana Taheri, Eri Banno, Takeshi Ujike

Int J Mol Sci· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis